Industry Perspectives

Healthcare privacy requires unified governance, live PHI visibility, vendor oversight, and timestamped evidence for continuous compliance.

Treat ISO 42001 as a certifiable AI management system to govern high‑risk clinical models, ensure oversight, and enforce vendor controls.

Encrypt every backup copy and separate keys: AES-256, TLS 1.2/1.3, BYOK/KMS, MFA/RBAC, immutable copies, and quarterly restore tests.

Require hour-based vendor notices, 24/7 named contacts, raw evidence sharing, subcontractor flow-downs, and annual tabletop tests.

Passive, low-latency monitoring for IoMT devices to spot firmware tampering, ransomware, lateral movement, and protect patient care.

Practical guide to cross-border AI telemedicine compliance: data mapping, lawful transfers, vendor oversight, human review, and technical controls.

Encrypt ePHI across layers - TLS 1.3, AES-GCM, ECC/RSA, IPsec, and S/MIME - with strict key management for HIPAA compliance.

Step-by-step checklist to verify vendor access: inventory, MFA, RBAC, JIT, logging, offboarding SLAs, and PHI controls.

Default to TLS 1.3 + ECDHE for portals/APIs, use mTLS for system links, keep RSA for legacy, and pilot post‑quantum for long‑term PHI.

Contain threats in minutes: revoke compromised identities, microsegment workloads, and keep EHRs online while limiting PHI exposure.

Drills only matter if you score them: 12 metrics tie detection, clinical impact, communications, cost, and action closure to patient safety.

Vendor access, APIs, and weak identity controls make healthcare supply chains vulnerable; focus on who, how they log in, and access duration.

How ransomware and device outages create patient-safety risks and trigger HIPAA, CMS, FDA, and state compliance actions.

Map vendor and fourth‑party links, align joint recovery playbooks, monitor continuously, and enforce recovery contract terms.

FDA cyber-device compliance lifecycle: scope, SBOM, threat→control→test traceability, eSTAR submission, postmarket monitoring.

Checklist: identify unsecured PHI, document the four-factor risk review, and meet HIPAA and state breach-notification deadlines.

Civil HIPAA penalties target organizations for compliance failures; criminal penalties target individuals for knowing PHI misuse.

Assess vendor data quality, model bias, and governance for safer healthcare predictive analytics; includes due diligence and ongoing monitoring.

Chatbot and virtual assistant vendors pose critical PHI risks — healthcare organizations must enforce strict vendor risk management and HIPAA safeguards.

Evaluate healthcare AI vendors for fairness, transparency, bias mitigation, and patient data rights using a practical ethics and compliance checklist.

Guidance on HIPAA-compliant AI data governance: privacy, de-identification, security controls, vendor risk management, and ongoing monitoring.

Assess and mitigate CDS AI risks—data privacy, model bias, cybersecurity, and data poisoning—through vendor due diligence, technical reviews, and continuous monitoring.

Protect research data and IP when working with AI drug discovery vendors. Learn top threats, governance steps, technical defenses, and continuous monitoring.

Concise guide to FDA pathways, required evidence, and postmarket controls for AI/ML medical devices (510(k), De Novo, PMA, PCCP).